» Articles » PMID: 17135643

Significance of Necrosis in Grading of Oligodendroglial Neoplasms: a Clinicopathologic and Genetic Study of Newly Diagnosed High-grade Gliomas

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2006 Dec 1
PMID 17135643
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: High-grade gliomas (HGGs; WHO grades 3-4) are highly diverse, with survival times ranging from months to years. WHO 2000 grading criteria for high-grade oligodendroglial neoplasms [anaplastic oligoastrocytoma (AOA) and anaplastic oligodendroglioma (AO)] remain subjective, and the existence of grade 4 variants is controversial.

Patients And Methods: Overall survival (OS) of 1,093 adult patients with a cerebral HGG newly diagnosed between 1990 and 2005 was analyzed by univariate and multivariate models for significance of the following factors: patient age, surgery type, year of diagnosis, endothelial proliferation, necrosis, oligodendroglial histology, treatment center, and chromosome 1p, 19q, 7p (EGFR), and 10q (PTEN) abnormalities by fluorescence in situ hybridization (FISH).

Results: Necrosis was a statistically significant predictor of poor OS on univariate and multivariate analyses in AOA but not in AO. Median OS for patients with necrotic AOA (22.8 months) was significantly worse than for patients with non-necrotic AOA (86.9 months; P < .0001) but was better than conventional glioblastomas (9.8 months; P < .0001). In addition to patient age, the following were significant independent prognostic factors (P .001): grade and surgery type for the entire HGG cohort; modified grade for AOA (3 v 4); and modified grade, 1p/19q codeletion status, and oligodendroglial histology for the 586 HGGs analyzed by FISH.

Conclusion: Stratification of AOA, but not of pure AO, into grades 3 and 4 on the basis of necrosis is prognostically justified and is more powerful than the current approach. Both routine histology and genetic testing provide independent, prognostically useful information.

Citing Articles

The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis.

Shi Y, Kang X, Ge Y, Cao Y, Li Y, Guo X BMC Neurol. 2024; 24(1):202.

PMID: 38877400 PMC: 11177380. DOI: 10.1186/s12883-024-03703-2.


Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma.

Zhao H, Dong J, Zhang J, Wang N, Liu Z, Yan X Front Mol Neurosci. 2023; 16:1117237.

PMID: 37465363 PMC: 10352027. DOI: 10.3389/fnmol.2023.1117237.


Effect of double mutations T790M/L858R on conformation and drug-resistant mechanism of epidermal growth factor receptor explored by molecular dynamics simulations.

Yan F, Liu X, Zhang S, Su J, Zhang Q, Chen J RSC Adv. 2022; 8(70):39797-39810.

PMID: 35558225 PMC: 9091310. DOI: 10.1039/c8ra06844e.


Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch.

Aboud O, Shah R, Vera E, Burton E, Theeler B, Wu J CNS Oncol. 2022; 11(1):CNS83.

PMID: 35142534 PMC: 8988255. DOI: 10.2217/cns-2021-0005.


Predictive Value of Temporal Muscle Thickness Measurements on Cranial Magnetic Resonance Images in the Prognosis of Patients With Primary Glioblastoma.

Liu F, Xing D, Zha Y, Wang L, Dong W, Li L Front Neurol. 2020; 11:523292.

PMID: 33304303 PMC: 7693652. DOI: 10.3389/fneur.2020.523292.